Efficacy and Safety Study for Paclitaxel plus Cisplatin Chemotherapy with Sintilimab in Women with Persistent, Recurent, or Metastatic Cervical Cancer
Latest Information Update: 03 Feb 2020
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Sintilimab (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 03 Feb 2020 New trial record